Table 2. IC₅₀ and CI₅₀ values of free drug and cMLVs therapeutics against OVCAR8 and NCI/ADR-RES.

Formulation CPT/PTX (molar ratio)	OVCAR8		NCI/ADR-RES
	IC50 (μM)	CI50	IC50 (μM)	CI50
CPT	21.09	—	79.36	—
PTX	5.85	—	9.86	—
CPT + PTX	1.52/1.52	0.33	7.13/7.13	0.81
cMLVs (CPT)	16.54	—	18.88	—
cMLVs (PTX)	2.69	—	8.44	—
cMLVs (4CPT + PTX)	0.92/0.23	0.14	6.05/1.51	0.49
cMLVs (CPT + PTX)	0.29/0.29	0.13	1.65/1.65	0.28
cMLVs (CPT + 4PTX)	0.16/0.63	0.24	0.93/3.73	0.50